BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
5.20
-0.83 (-13.76%)
At close: Apr 25, 2025, 4:00 PM
5.07
-0.13 (-2.50%)
After-hours: Apr 25, 2025, 6:12 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$724,500
Market Cap
19.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCTX News
- 1 day ago - BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering - GlobeNewsWire
- 1 day ago - Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher - Benzinga
- 2 days ago - BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™ - GlobeNewsWire
- 3 days ago - BriaCell Announces Four Clinical Data Presentations at ASCO 2025 - GlobeNewsWire
- 4 days ago - BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC) - GlobeNewsWire
- 10 days ago - BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer - GlobeNewsWire
- 4 weeks ago - BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference - GlobeNewsWire
- 5 weeks ago - Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire